Entresto 24 MG-26 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FGARL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,736
Award facts
- Contract value 100% obligated
- $15,735.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,735.92 to AmerisourceBergen Drug Corp for the supply of Entresto 24 mg-26 mg tablets (60-count units). This firm fixed-price delivery order, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery order constitutes a child contract action under AmerisourceBergen's larger federal contracting relationship with the Defense Logistics Agency.
This delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply military healthcare programs with a diverse range of pharmaceutical products and medical supplies. Entresto, a brand-name cardiac medication combining sacubitril and valsartan, supports the Defense Health Agency and military medical treatment facilities' pharmaceutical supply requirements. The rapid turnaround between award date and completion date reflects standard pharmaceutical delivery operations under this established prime vendor contract structure.
Quick answers
Who was awarded contract SPE2DB25FGARL?
SPE2DB25FGARL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FGARL worth?
The government has obligated $15,736 on SPE2DB25FGARL.
Is contract SPE2DB25FGARL an order under another contract?
Yes. SPE2DB25FGARL is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB25FGARL competed?
The extent of competition for SPE2DB25FGARL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award